"Montelukast (Merck brand name Singulair) is a selective Cys-LT1 ...

"Montelukast (Merck brand name Singulair) is a selective Cys-LT1 receptor antagonist that is used to control asthma symptoms in children and adults. Although safe and effective, the inter-patient variability in response is substantial (25-60% response rate), which is due in part to genetic variability. For example, we recently reported that polymorphisms in candidate genes that encode proteins in the LT pathway influence responsiveness to the drug." Co-sponsored by Merck http://clinicaltrials.gov/ct2/show/record/NCT00513760